This test detects the levels of galactocerebrosidase enzyme in biological samples, which is important for the metabolism of complex lipids. Its results are used in diagnosing genetic disorders such as Krabbe disease, where a deficiency of this enzyme leads to lipid accumulation in cells, causing serious health problems.

Individuals showing symptoms of Krabbe disease: such as muscle weakness, stiffness, or cognitive issues. Families with a history of genetic disorders: especially if there are confirmed cases of Krabbe disease. Newborns: as part of early screening programs for genetic diseases. Individuals planning to have children: if they have known genetic risks. People undergoing comprehensive health screenings for unspecified reasons: where signs of metabolic disorders may appear.

Muscle weakness: unexplained muscle weakness or loss of motor coordination. Cognitive issues: changes in memory or ability to concentrate. Speech problems: difficulty speaking or using language. Hearing loss: sudden or gradual decline in hearing ability. Visual problems: such as blurred vision or changes in eyesight. Stiffness or joint rigidity: difficulty moving or persistent pain. Mood changes: depression or sudden changes in emotional state.

What is the purpose of this test? It is used to determine the levels of galactocerebrosidase enzyme in the body, which helps in diagnosing Krabbe disease and other disorders. How is the test performed? A sample of blood or other biological fluids is taken and analyzed using FIA-MS/MS technology. How long does it take to get the results? Results usually take a few days up to a week, depending on the laboratory. Does the test require special preparation? Generally, no special preparation is needed, but it is recommended to consult the doctor for any specific instructions. What are the risks associated with the test? Risks are minimal and may include slight discomfort at the sample collection site. What do the test results mean? High or low results may indicate the presence of certain disorders, and the results should be discussed with the doctor to determine next steps. Can treatment affect the test results? Yes, some medications or treatments can affect enzyme levels, so it is important to inform the doctor of all ongoing therapies.

Values may slightly vary depending on the laboratory and method used. Generally, the normal enzyme level in adults is approximately 4.5 to 10 nanomoles per minute per milliliter of blood (nmol/min/mL).

Galactocerebrosidase Test Price | Lahalak Platform

An advanced test measuring Galactocerebrosidase enzyme activity, aiding in the early diagnosis of genetic neurological disorders and ensuring prompt, effective therapeutic intervention.

Prices starts from: 912.38 SAR

Scientific name: Galactocerebrosidase Enzyme Test

Galactocerebrosidase analysis by flow injection analysis–tandem mass spectrometry (FIA-MS/MS) is an advanced analytical procedure aimed at measuring the levels of the galactocerebrosidase enzyme in biological samples. This enzyme is important in complex lipid metabolism and is involved in diagnosing certain genetic disorders, such as Krabbe disease...

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 912.38 SAR

Included Services

Galactocerebrosidase Analysis by Flow Injection Analysis - Tandem Mass Spectrometry (FIA-MS/MS) Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

This test detects the levels of galactocerebrosidase enzyme in biological samples, which is important for the metabolism of complex lipids. Its results are used in diagnosing genetic disorders such as Krabbe disease, where a deficiency of this enzyme leads to lipid accumulation in cells, causing serious health problems.

Recommended groups

Individuals showing symptoms of Krabbe disease: such as muscle weakness, stiffness, or cognitive issues.
Families with a history of genetic disorders: especially if there are confirmed cases of Krabbe disease.
Newborns: as part of early screening programs for genetic diseases.
Individuals planning to have children: if they have known genetic risks.
People undergoing comprehensive health screenings for unspecified reasons: where signs of metabolic disorders may appear.

Symptoms indicative

Muscle weakness: unexplained muscle weakness or loss of motor coordination.
Cognitive issues: changes in memory or ability to concentrate.
Speech problems: difficulty speaking or using language.
Hearing loss: sudden or gradual decline in hearing ability.
Visual problems: such as blurred vision or changes in eyesight.
Stiffness or joint rigidity: difficulty moving or persistent pain.

FAQs

What is the purpose of this test? It is used to determine the levels of galactocerebrosidase enzyme in the body, which helps in diagnosing Krabbe disease and other disorders.
How is the test performed? A sample of blood or other biological fluids is taken and analyzed using FIA-MS/MS technology.
How long does it take to get the results? Results usually take a few days up to a week, depending on the laboratory.
Does the test require special preparation? Generally, no special preparation is needed, but it is recommended to consult the doctor for any specific instructions.
What are the risks associated with the test? Risks are minimal and may include slight discomfort at the sample collection site.
What do the test results mean? High or low results may indicate the presence of certain disorders, and the results should be discussed with the doctor to determine next steps.

Normal Levels

Values may slightly vary depending on the laboratory and method used. Generally, the normal enzyme level in adults is approximately 4.5 to 10 nanomoles per minute per milliliter of blood (nmol/min/mL).